<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Maternova, Inc.

    Maternova, Inc.

    Maternova, Inc. is the trusted resource for cutting edge medical innovations in ne...

    Maternova, Inc. is the trusted resource for cut...

    Amount Raised:    $104,976.00
    Fundraising Status:    EC
    Filing Type:    CF
    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focused...

    SELLAS Life Sciences Group, Inc. is a late-stag...

    Filing Type:    PU
    Proteon Therapeutics, Inc.

    Proteon Therapeutics, Inc.

    Proteon Therapeutics is working to deliver a new future for patients and families ...

    Proteon Therapeutics is working to deliver a ne...

    Filing Type:    PU
    iRhythm Technologies, Inc.

    iRhythm Technologies, Inc.

    iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are...

    iRhythm is a digital healthcare company redefin...

    Filing Type:    PU
    Microbot Medical Inc.

    Microbot Medical Inc.

    Microbot™, which was founded in 2010 and commenced operations in 2011, became a ...

    Microbot™, which was founded in 2010 and comm...

    Filing Type:    PU
    T2 Biosystems, Inc.

    T2 Biosystems, Inc.

    T2 Biosystems, a leader in the development and commercialization of innovative med...

    T2 Biosystems, a leader in the development and ...

    Filing Type:    PU
    BiondVax Pharmaceuticals Ltd.

    BiondVax Pharmaceuticals Ltd.

    BiondVax is an innovative biopharmaceutical company developing a universal flu vac...

    BiondVax is an innovative biopharmaceutical com...

    Filing Type:    PU
    aTyr Pharma, Inc.

    aTyr Pharma, Inc.

    aTyr’s mission is to translate newly discovered biological pathways to develop i...

    aTyr’s mission is to translate newly discover...

    Filing Type:    PU
    Morphic Holding, Inc.

    Morphic Holding, Inc.

    Morphic Therapeutic is leading the development of a new generation of oral integri...

    Morphic Therapeutic is leading the development ...

    Filing Type:    PU
    Agenus Inc.

    Agenus Inc.

    Agenus is an immuno-oncology company designed to deliver innovation with speed for...

    Agenus is an immuno-oncology company designed t...

    Filing Type:    PU
    Merus N.V.

    Merus N.V.

    Merus is a clinical-stage immuno-oncology company developing innovative full-lengt...

    Merus is a clinical-stage immuno-oncology compa...

    Filing Type:    PU
    Guardant Health, Inc.

    Guardant Health, Inc.

    We are a leading precision oncology company focused on helping conquer cancer glob...

    We are a leading precision oncology company foc...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.